Association of Choroid Plexus Inflammation on MRI With Clinical Disability Progression Over 5 Years in Patients With Multiple Sclerosis

Background and Objectives Inflammation of the choroid plexus (CP) has been reported in multiple sclerosis (MS). The AU1 association between CP inflammation and clinical disability progression is still under debate. The objective of the current study was to assess the relationship between measures of CP inflammation and investigate their associations with clinical disability progression in MS. Methods In this retrospective analysis of a longitudinal study, 174 patients with MS (118 with relapsing-remitting MS and 56 with progressive MS [PMS]) and 56 healthy controls (HCs), group matched for age and sex, were imaged on a 3T MRI scanner at baseline and after an average of 5.5 years of follow-up. T2 lesion volume (T2-LV) was assessed. Regional tissue volumes were calculated. CP volume was measured, and pseudo-T2 (pT2) mapping was performed to asses CP inflammation. Group comparisons and correlations were adjusted for age and sex. Results Patients with MS presented with significantly larger CP volume (p = 0.01) and increased CP pT2 (<0.001) at baseline, when compared with HCs. CP volume and CP pT2 did not significantly increase over the follow-up in the MS sample. However, baseline CP pT2 was associated with clinical disability progression at follow-up (p = 0.001), even after controlling for all other factors significantly associated with disability progression (p = 0.030), including T2-LV, normalized brain volume, normalized gray matter volume, and normalized thalamic volumes. Changes in CP volume and CP pT2 were not related to changes in clinical parameters such as relapse rate over the course of the follow-up. Discussion CP inflammation, as evidenced by MRI, is clinically relevant in MS. CP inflammation may have a relevant role in driving disease progression.

[1]  C. Granziera,et al.  Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder , 2022, Neurology: Neuroimmunology & Neuroinflammation.

[2]  J. Egan,et al.  Characterization of Age-Related Differences in the Human Choroid Plexus Volume, Microstructural Integrity, and Blood Perfusion Using Multiparameter Magnetic Resonance Imaging , 2021, Frontiers in Aging Neuroscience.

[3]  D. Reich,et al.  A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis , 2021, Nature.

[4]  V. Fleischer,et al.  Translational value of choroid plexus imaging for tracking neuroinflammation in mice and humans , 2021, Proceedings of the National Academy of Sciences.

[5]  C. Louapre,et al.  Choroid Plexus Enlargement in Inflammatory Multiple Sclerosis: 3.0-T MRI and Translocator Protein PET Evaluation. , 2021, Radiology.

[6]  F. Barkhof,et al.  In vivo imaging of chronic active lesions in multiple sclerosis , 2020, Multiple sclerosis.

[7]  Jeong Hyun Lee,et al.  Choroid plexus changes on magnetic resonance imaging in multiple sclerosis and neuromyelitis optica spectrum disorder , 2020, Journal of the Neurological Sciences.

[8]  Á. Pascual-Leone,et al.  Improving Choroid Plexus Segmentation in the Healthy and Diseased Brain: Relevance for Tau-PET Imaging in Dementia. , 2020, Journal of Alzheimer's disease : JAD.

[9]  H. D. de Vries,et al.  Inflammation of the choroid plexus in progressive multiple sclerosis: accumulation of granulocytes and T cells , 2020, Acta Neuropathologica Communications.

[10]  M. Ramanathan,et al.  A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis , 2019, Journal of Neurology.

[11]  C. Davatzikos,et al.  Inflammatory markers and imaging patterns of advanced brain aging in the general population , 2019, Brain Imaging and Behavior.

[12]  M. Dwyer,et al.  Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study , 2017, NeuroImage: Clinical.

[13]  L. Kappos,et al.  Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study , 2017, Multiple sclerosis.

[14]  J. Simard,et al.  Inflammation-dependent cerebrospinal fluid hypersecretion by the choroid plexus epithelium in posthemorrhagic hydrocephalus , 2017, Nature Medicine.

[15]  J. Correale,et al.  Progressive multiple sclerosis: from pathogenic mechanisms to treatment. , 2016, Brain : a journal of neurology.

[16]  A. MacKay,et al.  Measuring water content using T2 relaxation at 3T: Phantom validations and simulations. , 2016, Magnetic resonance imaging.

[17]  D. Ramasamy,et al.  A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients , 2016, Multiple sclerosis.

[18]  D. Arnold,et al.  Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: Implications for monitoring atrophy in clinical studies , 2014, NeuroImage: Clinical.

[19]  Stephen M. Smith,et al.  Permutation inference for the general linear model , 2014, NeuroImage.

[20]  Robert Zivadinov,et al.  Improved longitudinal gray and white matter atrophy assessment via application of a 4-dimensional hidden Markov random field model , 2014, NeuroImage.

[21]  F. Barkhof,et al.  Validation of the automated method VIENA: An accurate, precise, and robust measure of ventricular enlargement , 2014, Human brain mapping.

[22]  M. Battaglini,et al.  Evaluating and reducing the impact of white matter lesions on brain volume measurements , 2012, Human brain mapping.

[23]  Robert Zivadinov,et al.  Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis A case-control study , 2012, NeuroImage.

[24]  C. Larochelle,et al.  How do immune cells overcome the blood–brain barrier in multiple sclerosis? , 2011, FEBS letters.

[25]  Stephen M. Smith,et al.  A Bayesian model of shape and appearance for subcortical brain segmentation , 2011, NeuroImage.

[26]  Brian B. Avants,et al.  The optimal template effect in hippocampus studies of diseased populations , 2010, NeuroImage.

[27]  Rohit Bakshi,et al.  3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis , 2009, NeuroImage.

[28]  Stephen M. Smith,et al.  Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference , 2009, NeuroImage.

[29]  Alberto Romagnolo,et al.  Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: A neuropathological study , 2008, Journal of Neuroimmunology.

[30]  R. Ransohoff,et al.  Human cerebrospinal fluid central memory CD4+ T cells: Evidence for trafficking through choroid plexus and meninges via P-selectin , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[32]  A. Dale,et al.  Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.

[33]  J S Duncan,et al.  Technique for measuring hippocampal T2 relaxation time. , 1996, AJNR. American journal of neuroradiology.